Testing an AI system that checks eye photos for diabetic retinopathy
Tests an AI system for detecting diabetic retinopathy in adults with diabetes.
Plain-language title generated from the registry record
Registry title: Pivotal Trial for an Automated AI-based System for Detection of Diabetic Retinopathy
Key facts
- Where
- Jacksonville, United StatesSee the site
Where in United States
- Rovia Site NetworkJacksonville, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Digital Diagnostics, Inc.
- Trial code
- NCT07844317
- Record updated
- 28 September 2026
- Original description
Assessment of an autonomous AI system for diabetic retinopathy detection in adults with diabetes using retinal imaging.Read full original descriptionShow less
A Multicenter, Prospective Clinical Trial to Evaluate the Safety and Efficacy of an Automated System for Detecting Diabetic Retinopathy Using a Fundus Camera
Assessment of an autonomous AI system for diabetic retinopathy detection in adults with diabetes using retinal imaging.
Inclusion: 22 years of age or older; Diagnosis of DM; Ability to understand and willing to sign a written ICF.
Exclusion: Participants may be excluded if they have significant ocular conditions or prior ocular treatments that could interfere with retinal imaging or study assessments; are currently participating in another interventional ophthalmic clinical trial; have medical conditions that may affect study participation or data interpretation; are pregnant; or have contraindications to study-related imaging procedures.